"We continue to make targeted, strategic investments that give VWR access to the high growth biochemical industry, allowing us to more effectively leverage our infrastructure, and to provide enhanced solutions for our customers," said
Financial details of this acquisition remain confidential.
VWR (NASDAQ: VWR), headquartered in Radnor, PA, is a leading, independent provider of laboratory products, services and solutions with worldwide sales in excess of $4.1 billion in 2013. VWR enables science in laboratory and production facilities in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR offers a well-established network that reaches thousands of specialized laboratories and facilities spanning the globe. VWR has more than 8,500 associates working to streamline the way scientists, medical professionals and production engineers stock and manage their businesses. In addition, VWR supports its customers by providing other value-added service offerings, research support, laboratory services and operations services.
For more information about VWR, visit www.vwr.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vwr-acquires-national-biochemicals-300029655.html
News Provided by Acquire Media